EP
ELV icon

Eudaimonia Partners’s Elevance Health ELV Stock Holding History

Eudaimonia Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-229
Closed -$82K – 633
2021
Q1 		$82K Hold
229
– – 0.02% 514
2020
Q4 		$74K Hold
229
– – 0.02% 512
2020
Q3 		$62K Sell
229
-76
-25% -$20.4K 0.02% 506
2020
Q2 		$80K Hold
305
– – 0.03% 410
2020
Q1 		$69K Buy
305
+45
+17% +$12.3K 0.03% 400
2019
Q4 		$79K Buy
+260
New +$71.5K 0.03% 391

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eudaimonia Partners's ELV Position: Q2 2021 in Review

Eudaimonia Partners sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 229 shares — an estimated $82K sold.

Eudaimonia Partners first reported a position in ELV in Q4 2019 and held it in 6 quarters. The position peaked at $82K in Q1 2021. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • Eudaimonia Partners reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 229 Elevance Health shares in Q2 2021, an estimated $82K.
  • Eudaimonia Partners first reported a position in Elevance Health in Q4 2019 and held it in 6 quarters.
  • Eudaimonia Partners's Elevance Health position peaked at $82K in Q1 2021.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.